Serum leptin concentration and fuel homeostasis in healthy man

European Journal of Clinical Investigation

Volumn 27, Issue 3, 1997, Pages 206-211

  Tuominen, J A ^a   Ebeling, P ^a   Laquier, F W ^b   Heiman, M L ^b   Stephens, T ^b   Koivisto, V A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

cortisol; glycogen; growth hormone; insulin; leptin; ob gene

Indexed keywords

GLYCOGEN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; ENERGY EXPENDITURE; ENERGY METABOLISM; EXERCISE; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030892805     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.940642.x     Document Type: Article

References (34)

1. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond B Biol Sci 1953;140:578-92.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
3. -1 mice. Science 1995;269:540-3.
4. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene [see comments]. Science 1995;269:543-6.
5. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9.
6. Weigle DS, Bukowski TR, Foster DC et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995;96:2065-70.
7. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270: 15958-61.
8. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Med 1995;1:1311-4.
9. Stephens TW, Basinski M, Bristow PK et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-2.
10. Murakami T, Iida M, Shima K. Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Comm 1995;214:1260-7.
11. Saladin R, De Vos P, Guerre-Millo M et al. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527-9.
12. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin. Diabetes 1995;44:1467-70.
13. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1995;1:953-6.
14. Tartaglia LA, Dembski M, Weng X et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-71.
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
16. Ebeling P, Bourey R, Koranyi L et al. Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest 1993;92:1623-31.
17. Horton ES. Exercise and physical training: effects on insulin sensitivity and glucose metabolism. Diabetes Metab Rev 1986;2:1-17.
18. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
19. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreac-tive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
20. 125I-containing acylating agent. Biochem J 1973;133:529-39.
21. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 1983;24:96-9.
22. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 1971;33:732-8.
23. Laron Z, Mannheimer S. Measurement of human growth hormone. Description of the method and its clinical applications. Isr J Med Sci 1966;2:115-9.
24. Rolleri E, Zannino M, Orlandini S, Malvano R. Direct radioimmunoassay of plasma cortisol. Clin Chim Acta 1976;66:319.
25. Bergmeyer HU Metoden der enzymatischen Analyse, 3rd edn. Vol. II. Verlag Chemie: Weinheim, Germany, 1974.
26. Sinha MK, Ohannesian JP, Heiman ML. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996;97:1344-7.
27. MacDougald OA, Hwang Cheng-S, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 1995;92:9034-7.
28. Yki-Järvinen H, Koivisto VA, Karonen SL. Influence of body composition on insulin clearance. Clin Physiol 1985;5:45-52.
29. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen C, Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995;44(Suppl. 4):37-44.
30. Ketelslegers J, Maiter D, Maes M, Underwood L, Thissen J. Nutritional regulation of insulin-like growth factor I. Metabolism 1995;44(Suppl. 4):50-7.
31. Jorgensen J, Moller N, Wolthers T et al. Fuel metabolism in growth hormone-deficient adults. Metabolism 1995;44(Suppl. 4):103-7.
32. Kerr D, Tamborlane W, Rife F, Sherwin R. Effect of insulin-like growth factor I on the responses to and recognition of hypoglycemia in humans. J Clin Invest 1993;91:141-7.
33. Bermann M, Jaffe C, Tsai W, DeMott-Friberg R, Barkan A. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin. J Clin Invest 1994;94:138-45.
34. Tuominen JA, Ebeling P, Bourey R et al. Postmarathon paradox: Insulin resistance in the face of glycogen depletion. Am J Physiol 1996; 270: E336-43.